Alpha-Lipoprotein Deficiency Disease, Familial Medical Condition Defined & Explained

About The Medical Condition Alpha-Lipoprotein Deficiency Disease, Familial

Find the definition of the medical term Alpha-Lipoprotein Deficiency Disease, Familial. Alpha-Lipoprotein Deficiency Disease, Familial defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

Alpha-Lipoprotein Deficiency Disease, Familial

Alpha-Lipoprotein Deficiency Disease, Familial Medical Condition
What's The Definition Of The Medical Condition Alpha-Lipoprotein Deficiency Disease, Familial? A rare autosomal recessive familial disorder of cholesterol metabolism, characterized by extremely low HDL-cholesterol, reduced total cholesterol, and increased triglyceride levels in serum. Clinical features include the onset before age 20 years of HEPATOMEGALY; SPLENOMEGALY; the deposition of cholesterol in each TONSIL (creating a yellow-orange appearance); and RETINITIS PIGMENTOSA. A sensorimotor or distal sensory POLYNEUROPATHY occurs in approximately 50% of affected individuals. The condition is associated with decreased synthesis and increased catabolism of APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II, and a defect in cellular signaling and mobilization of lipids. (From Nat Genet 1998 Sep;20(1):96-8; Adams et al., Principles of Neurology, 6th ed, pp1347-8; Menkes, Textbook of Child Neurology, 5th ed, p118)

Alpha-Lipoprotein Deficiency Disease, Familial Medical Condition

What's The Definition Of The Medical Condition Alpha-Lipoprotein Deficiency Disease, Familial?

A rare autosomal recessive familial disorder of cholesterol metabolism, characterized by extremely low HDL-cholesterol, reduced total cholesterol, and increased triglyceride levels in serum. Clinical features include the onset before age 20 years of HEPATOMEGALY; SPLENOMEGALY; the deposition of cholesterol in each TONSIL (creating a yellow-orange appearance); and RETINITIS PIGMENTOSA. A sensorimotor or distal sensory POLYNEUROPATHY occurs in approximately 50% of affected individuals. The condition is associated with decreased synthesis and increased catabolism of APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II, and a defect in cellular signaling and mobilization of lipids. (From Nat Genet 1998 Sep;20(1):96-8; Adams et al., Principles of Neurology, 6th ed, pp1347-8; Menkes, Textbook of Child Neurology, 5th ed, p118)

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day

Protein Arginine Methyltransferase ‐ An enzyme that catalyzes the methylation of arginine residues…
Diiodide, Dequalinium ‐ A topical bacteriostat that is available as various salts. It…
Grayling ‐ A family of anadromous fish comprising SALMON, TROUT, whitefish,…
Low-Birth-Weight Infant ‐ An infant having a birth weight of 2500 gm. (5.5 lb.) or less…
NF-Y Protein ‐ A heterotrimeric DNA-binding protein that binds to CCAAT motifs…
Synteny ‐ The presence of two or more genetic loci on the same chromosome.…
Controls, Cost ‐ The containment, regulation, or restraint of costs. Costs are…
Streptomyces erythraea ‐ A genus of gram-positive bacteria whose spores are round to oval…
Peptide PHM ‐ A 27-amino acid peptide with histidine at the N-terminal and…
Systems, Cell-Free ‐ A fractionated cell extract that maintains a biological function.…